2007
DOI: 10.1016/j.vaccine.2007.09.053
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 52 publications
0
23
0
Order By: Relevance
“…Using the LC-MS/MS analysis, Aguilera et al, identified 18 different proteins that have been found to be strain specific and others are outer membrane vesicles of pathogens. These outer membrane vesicles shows binding with the host and increase the beneficial and positive effects on the host intestinal function [161]. Moreover, OMVs are known to be strong immunomodulatory, so they can also be used as potent pathogen-free vaccines after modifying its immunogenic contents.…”
Section: Significance Of Omv In the Development Of Probioticsmentioning
confidence: 99%
See 1 more Smart Citation
“…Using the LC-MS/MS analysis, Aguilera et al, identified 18 different proteins that have been found to be strain specific and others are outer membrane vesicles of pathogens. These outer membrane vesicles shows binding with the host and increase the beneficial and positive effects on the host intestinal function [161]. Moreover, OMVs are known to be strong immunomodulatory, so they can also be used as potent pathogen-free vaccines after modifying its immunogenic contents.…”
Section: Significance Of Omv In the Development Of Probioticsmentioning
confidence: 99%
“…Proteomic analysis of OMV has enabled researchers to identify new vaccine targets against various pathogens by increasing host immune responses. This includes neonatal meningitis E. coli (NMEC) [136], group A Streptococcus [160] and Neisseria meningitidis serogroup B [161].…”
Section: Significance Of Omv In the Development Of Probioticsmentioning
confidence: 99%
“…Vaccines based on capsular polysaccharides confer protection against bacteria of the same serogroup, but, unfortunately, the serogroup B capsular polysaccharide cannot be used due to its poor immunogenicity in humans and the potential risk of autoimmunity (17). Subcapsular antigens, mainly outer membrane proteins (OMPs) (1,11,48), have been extensively examined as alternative candidates for the development of a vaccine against this serogroup.…”
Section: Meningococcal Disease Is a Systemic Infection Caused Bymentioning
confidence: 99%
“…In parallel, techniques for proteomic and immunoproteomic analysis have been applied to characterize the antigen composition of commercial complex vaccines, and particularly some applications have arisen for the characterization of OMVs of pathogenic bacteria (Nally et al, 2005;Wheeler et al, 2007). For the meningococcus, such analytical approaches have recently identified new vaccine candidates (Delgado et al, 2007;Hsu et al, 2008).…”
Section: Introductionmentioning
confidence: 99%
“…A set of these antigens that show promise as vaccine candidates is currently under preclinical evaluation (Delgado et al, 2007). One of these antigens is the protein NMB0088 with an apparent molecular mass of approximately 50 kDa.…”
Section: Introductionmentioning
confidence: 99%